Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Hyloris Pharmaceuticals SA
XBRU:HYL
Hyloris Pharmaceuticals SA
XBRU:HYL
Price:
3.57
EUR
-2.19%
Market Cap:
€100m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Hyloris Pharmaceuticals SA
XBRU:HYL
|
BE |
|
Bridgestone Corp
F:BGT
|
JP |
|
Golden Cross Resources Ltd
ASX:GCR
|
AU |
|
Neptune Digital Assets Corp
XTSX:NDA
|
CA |
|
B
|
Bridgestone Corp
XMUN:BGT
|
JP |
|
Mitie Group PLC
LSE:MTO
|
UK |
|
A
|
Aristocrat Leisure Ltd
F:AC8
|
AU |
|
Stille AB
STO:STIL
|
SE |
|
Rithm Capital Corp
NYSE:RITM
|
US |
Wall St Price Targets
HYL Price Forecast
Based on 4 analysts
Based on 4 analysts
+200% Upside
from
€3.57
today
Hyloris Pharmaceuticals SA (HYL)’s 12-month stock price forecast through October 2027 has a consensus target of €10.71, implying 200% upside. The forecast is based on price targets from 4 Wall Street analysts.
HYL Analyst Rating
No ratings yet
No ratings yet
Hyloris Pharmaceuticals SA Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HYL's stock price target?
Price Target
10.71
EUR
10.71
EUR
According to Wall Street analysts, the average 1-year price target for HYL is 10.71 EUR with a low forecast of 6.06 EUR and a high forecast of 18.06 EUR.
What is the Revenue forecast for Hyloris Pharmaceuticals SA?
Projected CAGR
162%
162%
Over the last 7 years, the compound annual growth rate for Revenue has been 87%. The projected CAGR for the next 3 years is 162%.
What is the Gross Profit forecast for Hyloris Pharmaceuticals SA?
Projected CAGR
1 947%
1 947%
Over the last 7 years, the compound annual growth rate for Gross Profit has been 122%. The projected CAGR for the next 3 years is 1 947%.